Investors / Switzerland / Convergence Partners
Convergence Partners
Venture capital · Baar, Switzerland · Europe
Convergence Partners is a European venture capital firm that invests in founders building healthcare companies. It also actively supports the scale-up and internationalisation of its portfolio companies into Germany, China, the US and India.
Invests inHealthcare & Biotech
In its own wordshealthtechhealthcaremental healthwomen's healthlongevityb2b
Your fit with Convergence Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsConvergence Partners lists 32 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (69%), Gaming (5%) and Consumer (5%). 44% of its companies are based in Spain. It invests most often alongside Ship2B Ventures, Ship2B Foundation and Asabys Partners.
No funding round on record names Convergence Partners yet, so the figures come from its portfolio page.
Round figures show recent activity, not Convergence Partners' whole history. Rounds on record name 0 companies; its own site lists 32. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 69% | 15% |
| Gaming | 5% | 1% |
| Consumer | 5% | 3% |
| Mobility & Logistics | 5% | 1% |
| AI & Machine Learning | 5% | 18% |
| Enterprise Software | 3% | 8% |
| Space & Defense | 3% | 3% |
| Fintech | 3% | 12% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Ship2B Ventures | 9 |
| Ship2B Foundation | 6 |
| Asabys Partners | 2 |
| Creas | 2 |
| Criteria Venture Tech | 2 |
| Fondo Bolsa Social | 2 |
| Monte Carlo Capital | 2 |
| AI Capital | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 70th | 32 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 91th | 69% in its largest sector |
| Reach | 96th | 11 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers3197%
- No longer answers00%
- Points to another company13%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare Convergence Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
32 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Abi Global Health offers virtual care and consultations with healthcare professionals, empowered by AI | Healthcare & Biotech | Portfolio page | ||
| Aurimod develops a method for pain relief without medication using auricular Vagus-Nerve-Stimulation (aVNS) | Healthcare & Biotech | Portfolio page | ||
| The company provides AI-powered solutions to support breast imaging workflows for healthcare professionals and institutions. | Healthcare & Biotech | Portfolio page | ||
| CancerAppy is a biotech focused on the discovery and development of new therapeutic targets, based on its own artificial intelligence methodology | Healthcare & Biotech | Portfolio page | ||
| Cebiotex is a Phase 2 clinical-stage biotechnology company developing innovative local therapies for oncology. | Healthcare & Biotech | Portfolio page | ||
| Ciclogreen allows users to share car rides and earn money for each kilometer shared | Mobility & LogisticsSpace & Defense | Portfolio page | ||
| Clerkenwell Health conducts clinical trials for mental health and neurological conditions | Healthcare & Biotech | Portfolio page | ||
| The company developed photorealistic avatar technology for video calls, virtual reality apps, and games. | Enterprise SoftwareGaming | Portfolio page | ||
| Cytovation creates transformative medicines for patients with cancer by guiding and stimulating the immune system to recognize and eradicate tumors. | Healthcare & Biotech | Portfolio page | ||
| Dental Residency provides dental services to residential care homes, day centers, and individuals with functional diversity at home | Healthcare & Biotech | Portfolio page | ||
| Gasgon Medical is a medical device company developing innovative fluid management products for the clinical market | Healthcare & Biotech | Portfolio page | ||
| Gedea Biotech develops and commercializes treatments for vaginal infections, including bacterial vaginosis and vaginal fungal infections. | Healthcare & Biotech | Portfolio page | ||
| Inme Wellness offers retreats that combine ancestral wisdom with modern luxury and medical care for personal transformation and healing. | Healthcare & Biotech | Portfolio page | ||
| InterAx Biotech develops medicines by identifying the cellular mechanism of action and using it to drive the chemistry of the drug | Healthcare & Biotech | Portfolio page | ||
| Koiki provides consulting services in mobility and last-mile logistics, aiming to make urban mobility more human and sustainable. | Mobility & Logistics | Portfolio page | ||
| Metos creates and provides weather monitoring systems and related software and services for crop management and other applications. | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| Mowoot develops a non-invasive, device-based solution for bowel management | Healthcare & Biotech | Portfolio page | ||
Healthcare & BiotechConsumer | Portfolio page | |||
| Neotiv develops unique cognitive tests embedded in a digital platform to enable early medical assessment and follow-up of memory problems in the context of Alzheimer's disease. | Healthcare & Biotech | Portfolio page | ||
| The company empowers clinicians to embed leading therapy innovations to improve clinical and commercial outcomes | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- convergence-partners.ch
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 32
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Convergence Partners' profile as data
Pull Convergence Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/convergence-partners.ch
# also
GET /v1/firms/convergence-partners.ch/portfolio
GET /v1/firms/convergence-partners.ch/coinvestors
GET /v1/firms/convergence-partners.ch/news